Effects of herpes simplex virus on human oral cancer cells, and potential use of mutant viruses in therapy of oral cancer

Oral Oncology

Volumn 35, Issue 3, 1999, Pages 326-332

  Shillitoe, E J ^a   Gilchrist, E ^b   Pellenz, C ^a   Murrah, V ^b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Gene therapy; Oral cancer; Therapy

Indexed keywords

GANCICLOVIR;

ARTICLE; CANCER CELL; CYTOLYSIS; DRUG EFFECT; GROWTH INHIBITION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MOUTH CANCER; PLAQUE FORMING CELL; PRIORITY JOURNAL; VIRUS MUTANT; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; HERPESVIRUS 1, HUMAN; HUMANS; MICE; MICE, NUDE; MOUTH NEOPLASMS; MUTATION; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

EID: 0033012648     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00085-2     Document Type: Article

References (25)

1. Kenney S., Pagano J.S. Viruses as oncolytic agents: a new age for "therapeutic" viruses? Journal of the National Cancer Institute. 86:1994;1185-1186.
2. Kwong A.D., Frenkel N. The herpes simplex virus virion host shutoff function. Journal of Virology. 63:1989;4834-4839.
3. Johnson P.A., Miyanohara A., Levine F., Cahill T.F.T. Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. Journal of Virology. 66:1992;2952-2965.
4. Smythe W.R., Hwang H.C., Amin K.M., Eck S.L., Davidson B.L., Wilson J.M., et al. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Research. 54:1994;2055-2059.
5. Yang L., Chiang Y., Lenz H.J., Danenberg K.D., Spears C.P., Gordon E.M., et al. Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal cells. Human Gene Therapy. 9:1998;719-728.
6. Pavlovic J., Nawrath M., Tu R., Heinicke T., Moelling K. Anti-tumor immunity is involved in the thymidine kinase-mediated killing of tumors induced by activated Ki-ras(G12V). Gene Therapy. 3:1996;635-643.
7. Wilson K.M., Stambrook P.J., Bi W.L., Pavelic Z.P., Pavelic L., Gluckman J.L. HSV-tk gene therapy in head and neck squamous cell carcinoma. Enhancement by the local and distant bystander effect. Archives of Otolaryngology, Head and Neck Surgery. 122:1996;746-749.
8. Engel J.P., Madigan T.C., Peterson G.M. The transneuronal spread phenotype of herpes simplex virus type 1 infection of the mouse hind footpad. Journal of Virology. 71:1997;2425-2435.
9. Sacks P.G. Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer and Metastasis Reviews. 15:1996;27-51.
10. Johnson P.A., Best M.G., Friedman T., Parris D.S. Isolation of a herpes simplex virus type 1 mutant deleted for the essential UL42 gene and characterization of its null phenotype. Journal of Virology. 65:1991;700-710.
11. Smith, K.O. Relationships between the envelope and the infectivity of herpes simplex virus. Proceedings of the Society for Experimental Biology and Medicine. 1964;115:814-16.
12. Carmichael J., Mitchell J.B., DeGraff W.G., Gamson J., Gazdar A.F., Johnson B.E., et al. Chemosensitivity testing of human lung cancer cell lines using the MTT assay. British Journal of Cancer. 57:1985;540-547.
13. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Journal of Immunological Methods. 89:1986;271-277.
14. Webb H.E., Smithe C.E. Viruses in the treatment of human cancer. Lancet. 1:1970;1206-1208.
15. Asada T. Treatment of human cancer with mumps virus. Cancer. 34:1974;1907-1928.
16. Cassel W.A., Murray D.R., Phillips H.S. A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate. Cancer. 52:1983;856-860.
17. Cardinali M., Jakus J., Shah S., Ensley J.F., Robbins K.C., Yeudall W.A. p21(WAF1/Cip1) retards the growth of human squamous cell carcinomas in vivo. Oral Oncology. 34:1998;211-218.
18. Kramm C.M., Chase M., Herrlinger U., Jacobs A., Pechan P.A., Rainov N.G., et al. Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy. Human Gene Therapy. 8:1997;2057-2068.
19. Andreansky S., Soroceanu L., Flotte E.R., Chou J., Markert J.M., Gillespie G.Y., et al. Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors. Cancer Research. 57:1997;1502-1509.
20. Bolovan C.A., Sawtell N.M., Thompson R.L. ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures. Journal of Virology. 68:1994;48-55.
21. Perng G.C., Ghiasi H., Slanina S.M., Nesburn A.B., Wechsler S.L. High-dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild-type levels of spontaneous reactivation. Journal of Virology. 70:1996;2883-2893.
22. Glazenburg K.L., Peeters B.P.H., Pol J.M.A., Gielkens A.L.J., Moormann R.J.M. Construction and properties of pseudorabies virus recombinants with altered control of immediate-early gene expression. Journal of Virology. 69:1995;189-197.
23. Miyatake S., Iyer A., Martuza R.L., Rabkin S.D. Transcriptional targeting of herpes simplex virus for cell-specific replication. Journal of Virology. 71:1997;5124-5132.
24. Chen Z., Storthz K.A., Shillitoe E.J. Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences. Cancer Research. 57:1997;1614-1619.
25. Marchetti M.E., Smith C.A., Schaffer P.A. A temperature-sensitive mutation in a herpes simplex virus type 1 gene required for viral DNA synthesis maps to coordinates 0.609 through 0.614 in UL. Journal of Virology. 62:1988;715-721.